Martin David P, Sletten Christopher D, Williams Brent A, Berger Ines H
Department of Anesthesiology, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA.
Mayo Clin Proc. 2006 Jun;81(6):749-57. doi: 10.4065/81.6.749.
To test the hypothesis that acupuncture improves symptoms of fibromyalgia.
We conducted a prospective, partially blinded, controlled, randomized clinical trial of patients receiving true acupuncture compared with a control group of patients who received simulated acupuncture. All patients met American College of Rheumatology criteria for fibromyalgia and had tried conservative symptomatic treatments other than acupuncture. We measured symptoms with the Fibromyalgia Impact Questionnaire (FIQ) and the Multidimensional Pain Inventory at baseline, immediately after treatment, and at 1 month and 7 months after treatment. The trial was conducted from May 28, 2002, to August 18, 2003.
Fifty patients participated in the study: 25 in the acupuncture group and 25 in the control group. Total fibromyalgia symptoms, as measured by the FIQ, were significantly improved in the acupuncture group compared with the control group during the study period (P = .01). The largest difference in mean FIQ total scores was observed at 1 month (42.2 vs 34.8 in the control and acupuncture groups, respectively; P = .007). Fatigue and anxiety were the most significantly improved symptoms during the follow-up period. However, activity and physical function levels did not change. Acupuncture was well tolerated, with minimal adverse effects.
This study paradigm allows for controlled and blinded clinical trials of acupuncture. We found that acupuncture significantly improved symptoms of fibromyalgia. Symptomatic improvement was not restricted to pain relief and was most significant for fatigue and anxiety.
检验针刺可改善纤维肌痛症状这一假设。
我们对接受真针刺治疗的患者与接受模拟针刺治疗的对照组患者进行了一项前瞻性、部分盲法、对照、随机临床试验。所有患者均符合美国风湿病学会纤维肌痛标准,且除针刺外还尝试过保守对症治疗。我们在基线、治疗后即刻、治疗后1个月和7个月时,使用纤维肌痛影响问卷(FIQ)和多维疼痛量表测量症状。该试验于2002年5月28日至2003年8月18日进行。
50名患者参与了研究:针刺组25名,对照组25名。在研究期间,通过FIQ测量,针刺组的纤维肌痛总症状较对照组有显著改善(P = 0.01)。在1个月时观察到FIQ总分的最大差异(对照组和针刺组分别为42.2和34.8;P = 0.007)。在随访期间,疲劳和焦虑是改善最显著的症状。然而,活动和身体功能水平没有变化。针刺耐受性良好,不良反应最小。
本研究模式允许对针刺进行对照和盲法临床试验。我们发现针刺显著改善了纤维肌痛症状。症状改善不仅限于疼痛缓解,对疲劳和焦虑最为显著。